Fujimoto K, Arita H, Satomi K, Yamasaki K, et al. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma. Acta Neuropathol 2021 Jun 20. pii: 10.1007/s00401-021-02337.
PMID: 34148105